Search Results - Ryan A. Wilcox

Refine Results
  1. 1
    Cutaneous T‐cell lymphoma: 2014 Update on diagnosis, risk‐stratification, and management

    Cutaneous T‐cell lymphoma: 2014 Update on diagnosis, risk‐stratification, and management by Ryan A. Wilcox

    Published 2014
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Mogamulizumab: 2 birds, 1 stone

    Mogamulizumab: 2 birds, 1 stone by Ryan A. Wilcox

    Published 2015
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  3. 3
    Cancer-Associated Myeloproliferation: Old Association, New Therapeutic Target

    Cancer-Associated Myeloproliferation: Old Association, New Therapeutic Target by Ryan A. Wilcox

    Published 2010
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Cutaneous T‐cell lymphoma: 2011 update on diagnosis, risk‐stratification, and management

    Cutaneous T‐cell lymphoma: 2011 update on diagnosis, risk‐stratification, and management by Ryan A. Wilcox

    Published 2011
    Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    A three‐signal model of <scp>T</scp>‐cell lymphoma pathogenesis

    A three‐signal model of <scp>T</scp>‐cell lymphoma pathogenesis by Ryan A. Wilcox

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Cutaneous <scp>T</scp>‐cell lymphoma: 2016 update on diagnosis, risk‐stratification, and management

    Cutaneous <scp>T</scp>‐cell lymphoma: 2016 update on diagnosis, risk‐stratification, and management by Ryan A. Wilcox

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Cutaneous T‐cell lymphoma: 2017 update on diagnosis, risk‐stratification, and management

    Cutaneous T‐cell lymphoma: 2017 update on diagnosis, risk‐stratification, and management by Ryan A. Wilcox

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    Cutaneous B‐cell lymphomas: 2019 update on diagnosis, risk stratification, and management

    Cutaneous B‐cell lymphomas: 2019 update on diagnosis, risk stratification, and management by Ryan A. Wilcox

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    PTCL, NOS: An update on classification, risk-stratification, and treatment

    PTCL, NOS: An update on classification, risk-stratification, and treatment by J. Weiss, John Reneau, Ryan A. Wilcox

    Published 2023
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk‐stratification, and management

    Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk‐stratification, and management by Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox

    Published 2019
    Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    Cutaneous B‐cell lymphomas: 2021 update on diagnosis, risk‐stratification, and management

    Cutaneous B‐cell lymphomas: 2021 update on diagnosis, risk‐stratification, and management by Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Cutaneous T‐cell lymphomas: 2021 update on diagnosis, risk‐stratification, and management

    Cutaneous T‐cell lymphomas: 2021 update on diagnosis, risk‐stratification, and management by Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Cutaneous T‐cell lymphomas: 2023 update on diagnosis, risk‐stratification, and management

    Cutaneous T‐cell lymphomas: 2023 update on diagnosis, risk‐stratification, and management by Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Cutaneous B‐cell lymphomas: 2023 update on diagnosis, risk‐stratification, and management

    Cutaneous B‐cell lymphomas: 2023 update on diagnosis, risk‐stratification, and management by Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Signaling Through NK Cell-Associated CD137 Promotes Both Helper Function for CD8+ Cytolytic T Cells and Responsiveness to IL-2 But Not Cytolytic Activity

    Signaling Through NK Cell-Associated CD137 Promotes Both Helper Function for CD8+ Cytolytic T Cells and Responsiveness to IL-2 But Not Cytolytic Activity by Ryan A. Wilcox, Koji Tamada, Scott E. Strome, Lieping Chen

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Editorial: Challenges in peripheral T-cell lymphomas: from biological advances to clinical applicability

    Editorial: Challenges in peripheral T-cell lymphomas: from biological advances to clinical applicability by Luís Alberto de Pádua Covas Lage, Juliana Pereira, Ryan A. Wilcox

    Published 2023
    Get full text Get full text
    Editorial
    Save to List
    Saved in:
  17. 17
    Inhibition of Syk protein tyrosine kinase induces apoptosis and blocks proliferation in T-cell non-Hodgkin's lymphoma cell lines

    Inhibition of Syk protein tyrosine kinase induces apoptosis and blocks proliferation in T-cell non-Hodgkin's lymphoma cell lines by Ryan A. Wilcox, D X Sun, Anne J. Novak, Ahmet Doǧan, Stephen M. Ansell, Andrew L. Feldman

    Published 2009
    Get full text
    Carta
    Save to List
    Saved in:
  18. 18
    Time to Next Treatment as a Meaningful Endpoint for Trials of Primary Cutaneous Lymphoma

    Time to Next Treatment as a Meaningful Endpoint for Trials of Primary Cutaneous Lymphoma by Belinda A. Campbell, Julia Scarisbrick, Youn H. Kim, Ryan A. Wilcox, Christopher McCormack, H. Miles Prince

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Programmed death 1 is expressed in cutaneous infiltrates of mycosis fungoides and Sézary syndrome

    Programmed death 1 is expressed in cutaneous infiltrates of mycosis fungoides and Sézary syndrome by David A. Wada, Ryan A. Wilcox, Susan M. Harrington, Eugene D. Kwon, Stephen M. Ansell, Nneka I. Comfere

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    A retrospective comparative outcome analysis following systemic therapy in <scp>M</scp>ycosis fungoides and <scp>S</scp>ezary syndrome

    A retrospective comparative outcome analysis following systemic therapy in <scp>M</scp>ycosis fungoides and <scp>S</scp>ezary syndrome by Walter Hanel, Robert Briski, Charles W. Ross, Thomas F. Anderson, Mark Kaminski, Alexandra C. Hristov, Ryan A. Wilcox

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: